CNSP 8-K 2026-10-02

CNS Pharmaceuticals, Inc. (CNSP) 8-K dated 2026-10-02 — accession 0001683168-26-007552. This URL is the filing, not the CNSP hub.

CNS Pharmaceuticals, Inc. (CNSP) is a biotechnology company listed on NASDAQ.

CNS Pharmaceuticals, Inc. filed a 8-K on 2026-10-02. Accession 0001683168-26-007552.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CNSP revenue for 2023-12-31 was $27.7K. Net income was -$18.9M. CNSP currently screens at market cap $6.6M.

Not investment advice. The CNSP SEC hub lists recent forms. The stock page is the research view.